Home

Search results

Silica drug delivery matrix(Page)
The Natural Solution for Drug Delivery DelSiTech has developed a unique proprietary drug delivery technology based on biodegradable silica (S...

Small molecule drug delivery(Page)
nology for small molecule drug delivery Biodegradable silica-based technology offers multiple options for small molecule drug delivery needs. ...

Technology(Page)
The nanotech solution for drug delivery DelSiTech™Silica is an advanced delivery technology for parenteral and local administration of injecta...

DelSiTech and Bayer Partner to Develop Innovative Drug Delivery Technology for Ophthalmology(News)
>DelSiTech Ltd, a Finnish drug delivery technology and drug development company, and Bayer have signed a Collaboration and Technology Licence...

Drug delivery company DelSiTech Ltd appoints a new CEO(News)
”DelSiTech is an exciting drug delivery technology company which is a global leader in its technology segment. The company and its technology...

DelSiTech Featured in a Recent Ocular Drug Delivery Business Report(News)
g" target="_blank">Ocular Drug Delivery: Market Overview, Delivery Technologies, and Partnering Opportunities” covers innovative ocular dr...

Benefits(Page)
lability The silica-based drug delivery technology has multiple competitive advantages over other alternative delivery technologies Silica is ...

DelSiTech Ltd publishes an animated video on its drug delivery technology(News)
Finnish drug delivery technology company DelSiTech Ltd announced today that it has published an animated video on its silica bas...

Careers(Page)
orking with the future of drug delivery? In the near future we expect to hire pharmaceutical professionals for challenging positions with foll...

European Patent approval for new injectable drug delivery technology(News)
the field of silica based drug delivery technology. The continuously growing portfolio will help our customers to protect even better their i...

DelSiTech and MedImmune Presented Poster on Antibody Drug Delivery at AAPS Meeting(News)
iodegradable silica based drug delivery technology continues to demonstrate its capabilities in the formulation and delivery of biologicals an...

DelSiTech Ltd announces new website launch(News)
to DelSiTech’s innovative drug delivery technology and business activities. DelSiTech Ltd, which develops and commercializes its proprietar...

Company Profile(Page)
elSiTech is an innovative drug delivery technology company that helps its customers to turn their active agents into novel and useful therapeu...

Publications(Page)
ications The silica-based drug delivery technology and its scientific basis has been validated in numerous scientific studies since early 90's...

Delivery solutions for biological macromolecus(Page)
of choice for controlled drug delivery of biological macromolecules. We have succesfully developed formulations for protein drug delivery and...

DelSiTech Ltd announces positive patent news(News)
position is silica based drug delivery technology The Finnish drug delivery technology company DelSiTech Ltd is pleased to announce the C...

DelSiTech’s Silica Matrix for Ocular Delivery featured in ONdrugDelivery(News)
edition of ONdrugDelivery drug delivery, a leading drug delivery magazine freely available on the internet, focuses on ophthalmic dru...

DelSiTech receives EU funding from Horizon 2020 programme(News)
Finnish drug delivery company DelSiTech Ltd announced today that it has been granted a significant research funding by EU Research and Inn...

Patents(Page)
ts DelSiTech protects its drug delivery technology actively by patents. Currently, the silica technology is covered by ten patent families wor...

Technology applications(Page)
an with other alternative drug delivery technologies.  DelSiTech's drug delivery technology has a large array of applications in delivery of t...

DelSiTech enters into research collaboration with Orion Corporation(News)
nd proprietary DelSiTech® drug delivery technology in combination with its drug molecules for different therapeutic purposes. DelSiTech will...

DelSiTech Ltd starts new collaboration projects with two Animal Health companies(News)
The Finnish drug delivery technology company DelSiTech Ltd. announced today that it has initiated new projects with two undisclosed Animal Hea...

DelSiTech Ltd enters licensing agreement with Solani Therapeutics Ltd in animal health(News)
erinary drugs. Finnish drug delivery and development Company DelSiTech Ltd announced today that it has signed a technology licensing agreem...

DelSiTech Ltd files a new patent application in February 2007(News)
DelSiTech Ltd has filed a new patent application in February 2007. The new technology broadens significantly the ap...

Supergeneric drug developmet(Page)
ined with the DelSiTech's drug delivery technology to produce “supergenerics” with superior characteristics over the original brand product. T...

Business Strategy(Page)
iodegradable silica based drug delivery technology to biotech and pharma industry customers by providing service for fee, 2) Develop and comme...

Management(Page)
Chip Ltd, a polymer-based drug delivery company and Arrow Therapeutics, an antiviral drug development company owned by AstraZeneca. Dr. Griffi...

Why work with us(Page)
-stop shop opportunity in drug delivery up to early clinical proof-of concept. When working with DelSiTech, you can choose from a simple feasi...

Services(Page)
o demonstrate that silica drug delivery technology is compatible with your active molecule or activecomponent (e.g. viral vector). This includ...

Pipeline(Page)
ombining its silica-based drug delivery technology platform with known active substances to produce supergeneric products with superior charac...

DelSiTech Ltd raises significant R&D funding(News)
cal studies. Finnish drug delivery technology company DelSiTech Ltd announced today that it has successfully completed its latest financi...

DelSiTech Ltd expands its services to analytical support(News)
The Finnish drug delivery technology company DelSiTech Ltd announced today that it is now able to provide high quality analytical services to...

DelSiTech promotes Cora Griffin to Director, Head of Business Development(News)
Chip Ltd, a polymer-based drug delivery company and Arrow Therapeutics, an antiviral drug development company owned by AstraZeneca...

DelSiTech Secures Further Funding for In-House Program(News)
Finnish drug delivery technology company DelSiTech Ltd announced today that it has been awarded additional funding by...

DelSiTech CEO Lasse Leino interviewed for the benefits of silica based drug delivery on PharmaTelevison(News)
DelSiTech is pleased to provide a link to an interview on PharmaTelevison where Dr. Lasse Leino, CEO of DelSiTech discusses the technology...

Home(Page)
icable to a wide range of drug delivery needs Our partners Upcoming Events News DelSiTech is the leading technology specialist in biodegradabl...